Sandhya Deo

    • Manage the global patent portfolio of Usher III Initiative 

    • Obtained the first US patents covering combination HIV therapies for Gilead Sciences 

    • Vascular Biogenics Prices IPO 

    • Vitae Pharmaceuticals Completes Initial Public Offering  

    • Flexion $74 Million Initial Public Offering 

    • Cooley Advised Flexion on Initial Public Offering 

    • Cara Therapeutics $55 Million Initial Public Offering 

    • First US IPO of 2014 for GlycoMimetics